tiprankstipranks
Trending News
More News >
Ligand Pharma (LGND)
NASDAQ:LGND

Compare Ligand Pharma (LGND) vs. Competitors

Compare
830 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ligand Pharma
$196.54
$3.87B
94.38
77.80%
7 Buy
0 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$20.33
$2.57B
69.15
-29.28%
10 Buy
6 Hold
0 Sell
Moderate Buy
Scholar Rock Holding
$45.58
$4.65B
-14.31
4.99%
12 Buy
0 Hold
0 Sell
Strong Buy
Crinetics Pharmaceuticals
$55.42
$5.68B
-12.45
53.63%
12 Buy
0 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$71.12
$5.94B
-19.78
63.27%
21 Buy
1 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$17.41
$1.24B
-4.91
-62.82%
9 Buy
1 Hold
2 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
LGND
Ligand Pharma
196.08
85.00
76.52%
APLS
Apellis Pharmaceuticals
20.53
-9.20
-30.95%
SRRK
Scholar Rock Holding
46.53
2.63
5.99%
CRNX
Crinetics Pharmaceuticals
56.43
19.95
54.69%
KYMR
Kymera Therapeutics
71.12
30.83
76.52%
MLTX
MoonLake Immunotherapeutics
16.35
-25.12
-60.57%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts